NCHR’s Comments on FDA’s Draft Guidance on Levonorgestrel

March 23, 2020 National Center for Health Research’s Public Comments on FDA’s Draft Guidance on Levonorgestrel [Docket Number FDA-2007-D-0369] We are pleased to have the opportunity to comment on the FDA Draft Guidance on Levonorgestrel IUD devices for the design of bioequivalence studies supporting abbreviated new drug applications.  The National Center for Health Research (NCHR) is […]

Read More »

NCHR Signature on AB 1989 Opposition Letter

March 11, 2020. We oppose, unless amended AB 1989, the Menstrual Product Right to Know Act of 2020. Unlike cleaning products, less is known about the manufacture, ingredients and potential health impacts of menstrual products. People using menstrual products have the right to avoid exposures that will lead to allergic reactions.

Read More »

NCHR Statement Supporting Maryland House Bill to Ban State Funds for Artificial Turf and Playgrounds

March 5, 2020. Officials in communities all over the country have been misled by artificial turf salespeople. They were erroneously told that these products are safe.  But on the contrary, there is clear scientific evidence that these materials are harmful.  The only question is how much exposure is likely to be harmful to which children?  We should not be willing to take such a risk.  Our children deserve better.

Read More »